Patents by Inventor Philippe Le Bouteiller

Philippe Le Bouteiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
    Patent number: 10208124
    Abstract: The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM 1-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.
    Type: Grant
    Filed: June 2, 2015
    Date of Patent: February 19, 2019
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), MABLIFE
    Inventors: Philippe Le Bouteiller, Armand Bensussan
  • ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
    Publication number: 20150344572
    Abstract: The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM 1-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.
    Type: Application
    Filed: June 2, 2015
    Publication date: December 3, 2015
    Inventors: Philippe Le Bouteiller, Armand Bensussan
  • Anti-CD160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
    Patent number: 9045544
    Abstract: The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM 1-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.
    Type: Grant
    Filed: May 27, 2011
    Date of Patent: June 2, 2015
    Assignees: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE), MABLIFE
    Inventors: Philippe Le Bouteiller, Armand Bensussan
  • Angiogenic and Immunologic Applications of Anti-CD160 Specific Compounds Obtainable From mAb CL1-R2
    Publication number: 20150004170
    Abstract: The present invention relates to biological and medical applications of an anti-CD160 monoclonal antibody (CL1-R2 CNCM I-3204) and of the conservative equivalents thereof. It more particularly relates to the applications of these anti-CD160 compounds in the fields of EC angiogenesis, and NK and T cytokine production.
    Type: Application
    Filed: July 8, 2014
    Publication date: January 1, 2015
    Inventors: Armand Bensussan, Laurence Boumsell, Philippe Le Bouteiller
  • ANTI-CD160 SPECIFIC ANTIBODIES FOR THE TREATMENT OF EYE DISORDERS BASED ON NEOANGIOGENESIS
    Publication number: 20130122006
    Abstract: The present invention relates to the use of at least one anti-CD 160 antibody, preferably a compound selected from CL1-R2 monoclonal antibody (which may be obtained by the hybridoma CNCM I-3204), its conservative fragments and its conservative derivatives, for preparing a drug designed to treat neovascular eye diseases.
    Type: Application
    Filed: May 27, 2011
    Publication date: May 16, 2013
    Applicants: Mablife, INSERM (Institut National de la Sante et de la Recherche Medicale)
    Inventors: Philippe Le Bouteiller, Armand Bensussan
  • Angiogenic and immunoglobic applications of anti cd160 specific compounds obtainable from mab cl 1-r2
    Publication number: 20090317401
    Abstract: The present invention relates to biological and medical application of an anti-CD160 monoclonal antibody (CL1-R2 CNCM I-3204) an of the conservative equivalents thereof.
    Type: Application
    Filed: August 9, 2005
    Publication date: December 24, 2009
    Applicant: INSERM
    Inventors: Armand Bensussan, Laurence Boumsell, Philippe Le Bouteiller